Article

Bioinformatics for differential proteomics data between triple-negative breast cancer and luminal A subtype breast cancer

2020-01-15

Abstract excerpt

<title>Abstract</title> <p>Background The heterogeneity between different subtypes of breast cancer has been established. Triple-negative breast cancer (TNBC) is the type of breast cancer with the highest recurrence rate, metastasis rate, and worst prognosis, while luminal A breast cancer is the subtype with the best prognosis. To study the heterogeneity of the two subtypes of breast cancer is important. Methods...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ae36aa70-1e4c-5e79-b01c-f74bffcfb203
DOI: 10.21203/rs.2.20943/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bioinformatics for differential proteomics data between triple-negative breast cancer and luminal A subtype breast cancerDOI 10.21203/rs.2.20943/v1Read

Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancerSemantic proximity Read

Differentially Expressed Genes and Key Pathways in Triple Negative Breast Cancers: A Bioinformatics AnalysisSemantic proximity Read

Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific BiomarkersSemantic proximity Read

Heterogeneity of luminal A and HER2-positive breast cancer based on DIA quantitative proteomics and bioinformatics analysis techniquesSemantic proximity Read

Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis.Semantic proximity Read

The Proteomic Landscape of Triple-Negative Breast CancerSemantic proximity Read

Quantitative proteomics analysis of triple-negative breast cancersSemantic proximity Read

Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving PathwaysSemantic proximity Read

Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancerSemantic proximity Read

Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics AnalysisSemantic proximity Read

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read

Classification of triple-negative breast cancer based on immune cell infiltrationSemantic proximity Read